Cargando…

Biological Variation in Rotational Thromboelastometry in Patients with Atrial Fibrillation Receiving Rivaroxaban

Rotational thromboelastometry (ROTEM) is a viscoelastic hemostasis test used primarily in the management of bleeding after trauma or in cardiac surgery. To allow safe and valid clinical interpretation of test results, objective specifications for analytical performance are needed, which are generall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Božič Mijovski, Mojca, Antovic, Jovan P., Malmström, Rickard E., Mavri, Alenka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321519/ https://www.ncbi.nlm.nih.gov/pubmed/35877567 http://dx.doi.org/10.3390/jcdd9070205

Ejemplares similares

Apixaban concentration variability and relation to clinical outcomes in real-life patients with atrial fibrillation
por: Mavri, Alenka, et al.
Publicado: (2021)

The in vitro addition of idarucizumab to plasma samples from patients increases thrombin generation
por: Božič Mijovski, Mojca, et al.
Publicado: (2021)

Risk of Thromboembolic Events in Patients with Non-Valvular Atrial Fibrillation After Dabigatran or Rivaroxaban Discontinuation – Data from the Ljubljana Registry
por: Vene, Nina, et al.
Publicado: (2016)

Rivaroxaban in atrial fibrillation
por: Giorgi, Mariano A, et al.
Publicado: (2012)

HFpEF and Atrial Fibrillation: The Enigmatic Interplay of Dysmetabolism, Biomarkers, and Vascular Endothelial Dysfunction
por: Bosanac, Jure, et al.
Publicado: (2022)

Factors That Determine the Prothrombin Time in Patients With Atrial Fibrillation Receiving Rivaroxaban
por: Huang, Jen-Hung, et al.
Publicado: (2018)

Rivaroxaban in atrial fibrillation cardioversion: an update
por: Lavalle, Carlo, et al.
Publicado: (2019)

Application of Rotational Thromboelastometry in Patients with Acute Promyelocytic Leukemia
por: Sabljic, Nikica, et al.
Publicado: (2022)

Impact of Dabigatran Treatment on Rotation Thromboelastometry
por: Sokol, Juraj, et al.
Publicado: (2021)

Initial rivaroxaban dosing in patients with atrial fibrillation
por: Ablefoni, Kaja, et al.
Publicado: (2019)

Ex vivo reversal of effects of rivaroxaban evaluated using thromboelastometry and thrombin generation assay
por: Schenk, B., et al.
Publicado: (2016)

Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
por: Turpie, Alexander GG
Publicado: (2014)

Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving rivaroxaban or warfarin
por: Coleman, Craig I., et al.
Publicado: (2021)

Role of Thromboelastography and Rotational Thromboelastometry in the Management of Cardiovascular Diseases
por: Korpallová, Barbora, et al.
Publicado: (2018)

Rotational thromboelastometry to assess hypercoagulability in COVID-19 patients
por: van Veenendaal, Nadine, et al.
Publicado: (2020)

Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation
por: Jacobs, Maartje S., et al.
Publicado: (2017)

Stroke prevention with rivaroxaban in higher‐risk populations with atrial fibrillation
por: Diener, H.‐C., et al.
Publicado: (2015)

Comparative Effectiveness and Safety of Dabigatran and Rivaroxaban in Atrial Fibrillation Patients
por: Lai, Chao‐Lun, et al.
Publicado: (2017)

Hemorrhagic pericarditis associated with rivaroxaban in an atrial fibrillation patient with pacemaker
por: Rhew, Shi Hyun, et al.
Publicado: (2017)

Rivaroxaban-associated intracranial hemorrhage in Saudi atrial fibrillation patients
por: Alkhotani, Amal, et al.
Publicado: (2020)

Rivaroxaban-Associated Bullous Pemphigoid in a Patient With Atrial Fibrillation
por: Liang, Jiaming (Calvin), et al.
Publicado: (2021)

International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)
por: Beyer-Westendorf, Jan, et al.
Publicado: (2019)

Reference ranges for rotational thromboelastometry in male Sprague Dawley rats
por: Cruz, Mariana Vigiola, et al.
Publicado: (2017)

Rotational thromboelastometry results are associated with care level in COVID-19
por: Almskog, Lou M., et al.
Publicado: (2020)

Screening of COVID-19-associated hypercoagulopathy using rotational thromboelastometry
por: Iwasaki, Yudai, et al.
Publicado: (2020)

Hypothermic circulatory arrest induced coagulopathy: rotational thromboelastometry analysis
por: Ise, Hayato, et al.
Publicado: (2020)

Rotational thromboelastometry in critical phase of dengue infection: Association with bleeding
por: Wickramasinghe, Wasanthi, et al.
Publicado: (2022)

Use of Thromboelastography and Rotational Thromboelastometry in Otolaryngology: A Narrative Review
por: Marsee, Mathew K., et al.
Publicado: (2022)

Association between Lipoprotein Subfractions, Hemostatic Potentials, and Coronary Atherosclerosis
por: Poropat Flerin, Tadeja, et al.
Publicado: (2022)

Economic evaluation of rivaroxaban in stroke prevention for patients with atrial fibrillation in Greece
por: Kourlaba, Georgia, et al.
Publicado: (2014)

Role of rivaroxaban in the management of atrial fibrillation: insights from clinical practice
por: Vimalesvaran, Kavitha, et al.
Publicado: (2018)

Cost-Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation
por: Kim, Hyunmee, et al.
Publicado: (2018)

Rivaroxaban Precision Dosing Strategy for Real‐World Atrial Fibrillation Patients
por: Konicki, Robyn, et al.
Publicado: (2020)

Comparison of Inflammatory Mediators in Patients With Atrial Fibrillation Using Warfarin or Rivaroxaban
por: Martins, Gabriela Lopes, et al.
Publicado: (2020)

Risks of Stroke and Mortality in Atrial Fibrillation Patients Treated With Rivaroxaban and Warfarin
por: Alberts, Mark, et al.
Publicado: (2020)

Real‐World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation
por: Lin, Shin‐Yi, et al.
Publicado: (2019)

Rivaroxaban and apixaban in patients with atrial fibrillation; a real-world data
por: ASLAN, Onur, et al.
Publicado: (2022)

Comparison of co-administration of amiodarone and rivaroxaban to co-administration of dronedarone and rivaroxaban for hemorrhage risks after atrial fibrillation ablation
por: Zhang, Peng, et al.
Publicado: (2022)

Left Atrial Appendage Thrombosis During Therapy with Rivaroxaban in Elective Cardioversion for Permanent Atrial Fibrillation
por: Serra, Walter, et al.
Publicado: (2015)

The Correlation between the Triglyceride-Glucose Index and Coagulation Markers in Patients with Recent Acute Myocardial Infarction
por: Košuta, Daniel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_spjg78qkpi1276c3p0bhsegsho